Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ONABOTULINUMTOXINA Cause Hypertension? 124 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Hypertension have been filed in association with ONABOTULINUMTOXINA. This represents 0.3% of all adverse event reports for ONABOTULINUMTOXINA.

124
Reports of Hypertension with ONABOTULINUMTOXINA
0.3%
of all ONABOTULINUMTOXINA reports
14
Deaths
36
Hospitalizations

How Dangerous Is Hypertension From ONABOTULINUMTOXINA?

Of the 124 reports, 14 (11.3%) resulted in death, 36 (29.0%) required hospitalization, and 17 (13.7%) were considered life-threatening.

Is Hypertension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ONABOTULINUMTOXINA. However, 124 reports have been filed with the FAERS database.

What Other Side Effects Does ONABOTULINUMTOXINA Cause?

Drug ineffective (18,179) Off label use (9,698) Product preparation error (3,593) Multiple use of single-use product (2,781) Therapeutic response decreased (2,685) Headache (2,316) Injection site pain (2,143) Eyelid ptosis (1,853) Wrong technique in product usage process (1,477) Migraine (1,232)

What Other Drugs Cause Hypertension?

ADALIMUMAB (9,032) METHOTREXATE (7,143) RITUXIMAB (6,760) PREDNISONE (6,087) INFLIXIMAB (5,874) ETANERCEPT (5,677) TOCILIZUMAB (5,492) ABATACEPT (5,114) TOFACITINIB (4,991) ALENDRONATE (4,373)

Which ONABOTULINUMTOXINA Alternatives Have Lower Hypertension Risk?

ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC ONABOTULINUMTOXINA vs ONASEMNOGENE ABEPARVOVEC-XIOI ONABOTULINUMTOXINA vs ONBREZ ONABOTULINUMTOXINA vs ONDANSETRON ONABOTULINUMTOXINA vs ONFI

Related Pages

ONABOTULINUMTOXINA Full Profile All Hypertension Reports All Drugs Causing Hypertension ONABOTULINUMTOXINA Demographics